[Excretion of urinary steroids before and after administration of beta 1-24 corticotropin in patients with cancer of the breast].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000311:Adrenal Glands / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000652:urine*; D002849:Chromatography, Gas; D004967:Estrogens / Q000652:urine; D005260:Female; D005470:Fluorometry; D006801:Humans; D011276:Pregnanediol / Q000652:urine; D011279:Pregnanetriol / Q000652:urine; D013256:Steroids / Q000652:urine*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D013256:Steroids; D011279:Pregnanetriol; D000324:Adrenocorticotropic Hormone; D011276:Pregnanediol
Excrétion des stéroödes urinaire avant et après administration de beta 1-24 corticotropine chez des patientes atteintes de cancer du sein.